InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

- Current share price for OSL : $0.720

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Change of Registered Office and Principal Place of Business 1 Mar 2021 9:09AM $0.100 $0.720 risen by 620%
$26 Business update call transcript 26 Feb 2021 8:12AM $0.110 $0.720 risen by 554.55%
$26 Half Yearly Report and Accounts 23 Feb 2021 12:15PM $0.110 $0.720 risen by 554.55%
$26 Half-Yearly Report Results 23 Feb 2021 12:15PM $0.110 $0.720 risen by 554.55%
$26 OncoSil Investor Update 18 Feb 2021 10:05AM $0.125 $0.720 risen by 476%
$26 Business Update - Conference Call Notification 16 Feb 2021 4:50PM $0.115 $0.720 risen by 526.09%
$26 Appointment of Chief Medical Officer & Medical Affairs Head 10 Feb 2021 4:30PM $0.115 $0.720 risen by 526.09%
$26 Appendix 4C - quarterly 28 Jan 2021 5:05PM $0.130 $0.720 risen by 453.85%
$26 Cancellation of shares under the Employee Share Plan 28 Jan 2021 9:31AM $0.130 $0.720 risen by 453.85%
$26 Initial Director's Interest Notice 21 Jan 2021 6:11PM $0.130 $0.720 risen by 453.85%
$26 Appointment of Chief Executive Officer 21 Jan 2021 4:09PM $0.130 $0.720 risen by 453.85%
$26 OncoSil FY21 half yearly review 18 Jan 2021 4:10PM $0.130 $0.720 risen by 453.85%
$26 Final Director's Interest Notice 18 Dec 2020 5:59PM $0.130 $0.720 risen by 453.85%
$26 Change of Director's Interest Notice 18 Dec 2020 5:59PM $0.130 $0.720 risen by 453.85%
$26 Change of Director's Interest Notice 18 Dec 2020 5:58PM $0.130 $0.720 risen by 453.85%
$26 Cancellation of shares under the Employee Share Plan 18 Dec 2020 5:57PM $0.130 $0.720 risen by 453.85%
$26 Termination of Mr Daniel Kenny as Chief Executive Officer 2 Dec 2020 9:29AM $0.165 $0.720 risen by 336.36%
$26 Change of Director's Interest Notice 5 Nov 2020 3:59PM $0.165 $0.720 risen by 336.36%
$26 Appendix 2A 5 Nov 2020 1:02PM $0.160 $0.720 risen by 350%
$26 OncoSil receives Swiss regulatory approval 5 Nov 2020 9:57AM $0.150 $0.720 risen by 380%
$26 Change of Director's Interest Notice 29 Oct 2020 9:30AM $0.130 $0.720 risen by 453.85%
$26 Change of Director's Interest Notice 27 Oct 2020 2:42PM $0.135 $0.720 risen by 433.33%
$26 OncoSil achieves first commercial sale 22 Oct 2020 8:35AM $0.135 $0.720 risen by 433.33%
$26 Appendix 4C - quarterly 21 Oct 2020 3:44PM $0.140 $0.720 risen by 414.29%
$26 Results of the OncoSil 2020 Annual General Meeting 20 Oct 2020 5:44PM $0.140 $0.720 risen by 414.29%

476 - 500 of 814 results

Page 20 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.